Ignite Creation Date:
2024-05-05 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00047346
Status:
COMPLETED
Last Update Posted:
2013-01-23
First Post:
2002-10-03
Brief Title:
Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Recurrent Adult Primary Liver Cancer |
| Adult Primary Hepatocellular Carcinoma |
| Advanced Adult Primary Liver Cancer |
| Localized Unresectable Adult Primary Liver Cancer |
Keywords: